| 11/16/2026 8:18 AM | Vir Biotechnology (1706431) Filer | Form 424B5 | |
| 11/13/2026 8:41 PM | Vir Biotechnology (1706431) Filer | Form 424B5 | |
| 11/13/2026 8:47 PM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/10/2026 8:35 AM | STATE STREET CORP (93751) Filed by STATE STREET CORP (93751) Filed by Vir Biotechnology (1706431) Subject | Form SCHEDULE 13G | |
| 11/09/2026 7:31 AM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/06/2026 5:55 PM | ARCH Venture Fund IX, L.P. (1666306) Filed by Vir Biotechnology (1706431) Subject | Form SCHEDULE 13D/A | |
| 11/04/2026 4:12 PM | Vir Biotechnology (1706431) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/04/2026 3:10 PM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/04/2026 1:56 PM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/03/2026 9:15 AM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/28/2026 12:32 PM | Topalian Suzanne Louise (2159860) Reporting Vir Biotechnology (1706431) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for VIR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vir Biotechnology and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/28/2026 12:34 PM | Topalian Suzanne Louise (2159860) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/28/2026 7:37 AM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/27/2026 4:25 PM | BlackRock, Inc. (2012383) Filed by Vir Biotechnology (1706431) Subject | Form SCHEDULE 13G/A | |
| 10/14/2026 7:35 AM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/08/2026 7:38 AM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/06/2026 1:14 PM | Sawaf Aziz (1961289) Reporting Vir Biotechnology (1706431) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 10/01/2026 7:34 AM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/17/2026 9:15 AM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/09/2026 9:57 AM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/25/2026 10:07 AM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/24/2026 4:11 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/21/2026 2:24 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/12/2026 1:30 PM | MORE ROBERT J (1207792) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/07/2026 10:10 AM | STATE STREET CORP (93751) Filed by STATE STREET CORP (93751) Filed by Vir Biotechnology (1706431) Subject | Form SCHEDULE 13G | |
| 08/05/2026 4:20 PM | Vir Biotechnology (1706431) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/05/2026 3:09 PM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/31/2026 10:39 AM | VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by Vir Biotechnology (1706431) Subject | Form SCHEDULE 13G/A | |
| 06/29/2026 2:06 PM | Ramasastry Saira (1547959) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/10/2026 5:20 PM | Coughlin Timothy (1376043) Reporting Vir Biotechnology (1706431) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 06/10/2026 5:21 PM | Coughlin Timothy (1376043) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 3:27 PM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/02/2026 4:31 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 4:35 PM | Napolitano Janet (1821008) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 2:03 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/01/2026 12:04 PM | Napolitano Janet (1821008) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/28/2026 6:23 PM | BISCHOFBERGER NORBERT W (1190273) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 6:24 PM | Farid Ramy (1797707) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 6:24 PM | Hatfield Jeffrey S. (1609879) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 6:25 PM | MORE ROBERT J (1207792) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 6:25 PM | Napolitano Janet (1821008) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
I'm handing you this one free (Ad) Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company.
That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th. See today's free stock pick before the December 8th deadline here |
| 05/28/2026 6:25 PM | Sigal Charles Elliott (1661908) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 8:01 AM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 8:00 PM | SB INVESTMENT ADVISERS (0) UK Vir Biotechnology (1706431) Subject | Form SCHEDULE 13G/A | |
| 05/04/2026 11:35 AM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/30/2026 4:43 PM | De Backer Marianne (1797819) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/29/2026 2:50 PM | VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by Vir Biotechnology (1706431) Subject | Form SCHEDULE 13G | |
| 04/16/2026 3:05 PM | Vir Biotechnology (1706431) Filer | Form ARS | |
| 04/16/2026 7:46 AM | Vir Biotechnology (1706431) Filer | Form DEF 14A | |
| 04/16/2026 7:49 AM | Vir Biotechnology (1706431) Filer | Form DEFA14A | |
| 04/07/2026 3:50 PM | De Backer Marianne (1797819) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/06/2026 2:23 PM | De Backer Marianne (1797819) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/02/2026 9:46 AM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 12:55 PM | VANGUARD GROUP INC (102909) Filed by Vir Biotechnology (1706431) Subject | Form SCHEDULE 13G/A | |
| 03/24/2026 3:35 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 2:49 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 8:42 AM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 11:10 AM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 8:01 AM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/26/2026 4:17 PM | Vir Biotechnology (1706431) Filer | Form 424B5 | |
| 02/26/2026 4:20 PM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/25/2026 8:00 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/25/2026 9:48 AM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/25/2026 8:48 AM | Eisner Mark (1834161) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 6:09 PM | De Backer Marianne (1797819) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 6:10 PM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 6:11 PM | Eisner Mark (1834161) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 6:12 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 6:13 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 4:16 PM | Eisner Mark (1834161) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 3:57 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 3:53 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 3:33 PM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 3:42 PM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 4:27 PM | Vir Biotechnology (1706431) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/23/2026 4:29 PM | Vir Biotechnology (1706431) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/23/2026 4:16 PM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/23/2026 3:52 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 3:32 PM | De Backer Marianne (1797819) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 3:34 PM | Eisner Mark (1834161) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 3:18 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 3:22 PM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/18/2026 2:38 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 11:28 AM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/14/2026 8:00 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/12/2026 7:07 AM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/05/2026 12:57 PM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/02/2026 3:29 PM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 3:25 PM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/02/2025 6:48 PM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 3:30 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Every Starlink dish pays this stock (Ad) There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it.
Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th.
This free pick names the public company collecting on every unit. Claim your free stock pick before December 8th |
| 11/25/2025 8:00 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/18/2025 1:47 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 2:20 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |